$2.19 Billion is the total value of BRADLEY FOSTER & SARGENT INC/CT's 350 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CCJ | Exit | Cameco Corporation | $0 | – | -10,020 | -100.0% | -0.01% | – |
| XLY | Exit | Select Sector S&P Consumer Ind | $0 | – | -2,725 | -100.0% | -0.01% | – |
| BEN | Exit | Franklin Resources | $0 | – | -4,038 | -100.0% | -0.01% | – |
| HCN | Exit | Health Care REIT Inc. | $0 | – | -2,670 | -100.0% | -0.01% | – |
| SSYS | Exit | Stratasys Ltd | $0 | – | -4,303 | -100.0% | -0.01% | – |
| AESPRC | Exit | AES Tr III CV 6.75% C7/21/08@5pfd cv | $0 | – | -4,500 | -100.0% | -0.01% | – |
| GSK | Exit | GlaxoSmithKline PLC | $0 | – | -4,953 | -100.0% | -0.01% | – |
| XEL | Exit | XCEL Energy | $0 | – | -6,450 | -100.0% | -0.01% | – |
| KONAQ | Exit | Kona Grill Inc | $0 | – | -8,000 | -100.0% | -0.01% | – |
| MAR | Exit | Marriott International | $0 | – | -2,606 | -100.0% | -0.01% | – |
| RCI | Exit | Rogers Communication | $0 | – | -7,205 | -100.0% | -0.01% | – |
| JUNO | Exit | Juno Therapeutics, Inc | $0 | – | -4,445 | -100.0% | -0.01% | – |
| PDCO | Exit | Patterson Companies Inc | $0 | – | -5,770 | -100.0% | -0.01% | – |
| XRX | Exit | Xerox | $0 | – | -25,100 | -100.0% | -0.02% | – |
| SLGN | Exit | Silgan Holdings Inc | $0 | – | -7,625 | -100.0% | -0.02% | – |
| TTGT | Exit | TechTarget, Inc | $0 | – | -44,550 | -100.0% | -0.02% | – |
| GCI | Exit | Gannett | $0 | – | -16,820 | -100.0% | -0.03% | – |
| IRM | Exit | Iron Mountain | $0 | – | -27,888 | -100.0% | -0.05% | – |
| HII | Exit | Huntington Ingalls Industries | $0 | – | -10,805 | -100.0% | -0.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft | 41 | Q3 2023 | 5.6% |
| Apple Inc | 41 | Q3 2023 | 5.0% |
| J P Morgan Chase | 41 | Q3 2023 | 3.7% |
| Danaher | 41 | Q3 2023 | 3.7% |
| Pepsico | 41 | Q3 2023 | 2.4% |
| Johnson & Johnson | 41 | Q3 2023 | 2.3% |
| Thermo Fisher Scientific | 41 | Q3 2023 | 2.8% |
| Walt Disney | 41 | Q3 2023 | 2.5% |
| Marsh & McLennan | 41 | Q3 2023 | 2.0% |
| Merck | 41 | Q3 2023 | 2.0% |
View BRADLEY FOSTER & SARGENT INC/CT's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| METROLOGIC INSTRUMENTS INC | February 11, 2000 | 293,562 | 5.4% |
View BRADLEY FOSTER & SARGENT INC/CT's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-08 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-03-11 |
View BRADLEY FOSTER & SARGENT INC/CT's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.